Company / Current Assets
Pasithea Therapeutics Corp. Current Assets History
FY2021-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$34.1M
FY2022
5-year range
$34.1M / $53.3M
FY2021-FY2022
Trend
-36.1%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$34M in FY2022.
Current Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, current assets decreased 36.1% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.26 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $34.1M | -36.1% |
| FY2021 | $53.3M | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026